Catherine Kelleher

Catherine (Cass) Kelleher is a physician with more than 14 years of experience in the biopharmaceutical industry and a further 14 years in academic medicine as an internist, nephrologist and geriatrician. Catherine was Associate Professor of Medicine at the University of Colorado where she was Co-PI on the HALT-PKD clinical study. Catherine started her career in the industry at Amgen and has worked in multiple therapeutic areas in drug development including nephrology and rheumatology. Recent positions held were in the complement space developing drugs to treat rare diseases including as Senior Vice President of Clinical Development at ChemoCentryx.